Therapeutic Uses
Antiretroviral / Anti-HIV
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Etravirine-d4 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Etravirine-d4 usage and description
Etravirine D4, also known as TMC-125 D4, is a deuterated form of the antiretroviral drug Etravirine. Etravirine D4 is used in the treatment of human immunodeficiency virus (HIV) infections. It belongs to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of drugs. Etravirine D4 works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV virus.
The chemical formula of Etravirine D4 is C20H12D4N4O3. It has a molecular weight of 376.41 g/mol. The drug is available in tablet form in the strength of 200mg.
Etravirine D4 is usually prescribed as a part of combination therapy for HIV treatment. It is taken orally, with or without food. The recommended dosage of Etravirine D4 is 200mg twice daily. The drug should not be taken with other NNRTIs or protease inhibitors as it can lead to drug interactions.
Etravirine D4 is metabolized in the liver by the cytochrome P450 enzyme system. The drug has a half-life of 40-45 hours, and its clearance is mainly through feces.
Etravirine D4 has been found to be effective in reducing viral load and increasing CD4 cell counts in HIV patients. However, like all drugs, Etravirine D4 can cause side effects such as headache, nausea, diarrhea, and rash. Patients with a history of liver disease should be monitored closely while taking this medication.
